New drug combo could spare bladder cancer patients from Life-Altering surgery
NCT ID NCT07475806
Summary
This study is testing whether a combination of two drugs, enfortumab vedotin and pembrolizumab, can help people with muscle-invasive bladder cancer avoid having their bladder surgically removed. The standard treatment involves chemotherapy followed by complete bladder removal, which causes major life changes. Researchers want to see if this drug combination can effectively control the cancer while allowing patients to keep their bladder intact for at least two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.